THE DEAL, AT A GLANCE
From the announcementEpitel
01What it doesEpitel is initially focused on seizure detection and diagnosis.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Catalyst Health Ventures, Genoa Ventures, newFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedEpitel raised $26M Series B, announced 2026-07-28From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersEpitel's $26M Series B represents a mid-market Enterprise Software & SaaS financing in a sector with substantial trailing 30-day capital flow, positioning the company…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Epitel · Financing Record
Explore source-linked visual explanations for Epitel. Unsupported claims are withheld while source review continues.
Record 9108 · Recorded date: 2026-07-28
Explore company records →